PB1862: BRUIN CLL-313: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS BENDAMUSTINE+RITUXIMAB IN UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC L... by W. Jurczak, C. Dartigeas, M. Coscia, P. Ganly, G. Al-Jazayrly, C. Wang, K. Bao, C. C. Leow, S. Shahda, P. L. Zinzani

Get full text

P1351: CHARACTERIZING ALLOGENEIC STEM CELL TRANSPLANTATION SAFETY IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES AFTER PEMBROLIZUMAB THERAPY by J. Kuruvilla, P. Armand, A. F. Herrera, V. Ribrag, P. Brice, C. Thieblemont, B. Von Tresckow, E. Kim, P. Marinello, S. Chakraborty, R. Orlowski, P. L. Zinzani

Get full text

P1178: BRENTUXIMAB VEDOTIN IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL: SAFETY AND EFFICACY RESULTS FROM THE SAFETY RUN-IN PERIOD OF T... by N. L. Bartlett, C. A. Yasenchak, K. K. Ashraf, W. N. Harwin, J. Orcutt, P. Kuriakose, P. L. Zinzani, A. Mamidipalli, K. Fenton, C. Glenn, G. Nowakowski

Get full text

P1104: A PHASE 1 STUDY EVALUATING SAFETY AND EFFICACY OF PARSACLISIB IN COMBINATION WITH BENDAMUSTINE + OBINUTUZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (CI... by M. Hamadani, M. Coleman, R. Boccia, J. Duras, M. Hutchings, P. L. Zinzani, R. Cordoba, M. B. Oreiro, V. Williams, M. Stouffs, P. Langmuir, J.-M. Sancho

Get full text

P1123: TEMPO: A PHASE 2, RANDOMIZED, OPEN-LABEL, 2-ARM STUDY COMPARING TWO INTERMITTENT DOSING SCHEDULES OF DUVELISIB IN SUBJECTS WITH INDOLENT NON-HODGKIN LYMPHOMA (INHL) by V. Vorobyev, D. H. Yoon, M. Kaźmierczak, S. Grosicki, C. Tarella, A. Genua, J. S. Kim, D. Cohan, M. Daugherty, I. W. Flinn, P. L. Zinzani, L. I. Gordon

Get full text

PB2111: SUBGROUP ANALYSIS IN RE-MIND2, AN OBSERVATIONAL, RETROSPECTIVE COHORT STUDY OF TAFASITAMAB + LENALIDOMIDE VERSUS SYSTEMIC THERAPIES IN PATIENTS WITH RELAPSED/REFRACTORY DIF... by G. S. Nowakowski, D. H. Yoon, E. Joffe, P. L. Zinzani, L. Sabatelli, E. E. Waltl, C. G. Alvero, G. Hess, P. Riedell, K. Kim, D. Brixner, G. Salles

Get full text

P683: A FIRST-IN-HUMAN PHASE 1 STUDY OF ORAL LOXO-338, A SELECTIVE BCL2 INHIBITOR, IN PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES (TRIAL IN PROGRESS) by W. Jurczak, A. J. Alencar, G. S. Guru Murthy, M. Hoffmann, J. M. Pagel, V. Patel, J. M. Pauff, P. L. Zinzani, S. Le Gouill, A. R. Mato, L. E. Roeker

Get full text

PB1863: BRUIN CLL-322: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF FIXED DURATION PIRTOBRUTINIB+VENETOCLAX AND RITUXIMAB VS VENETOCLAX AND RITUXIMAB IN PREVIOUSLY TREATED CLL/SLL (TR... by A. R. Mato, W. G. Wierda, J. M. Pagel, M. S. Davids, P. L. Zinzani, Y. Lu, H. Liu, S. Shahda, C. C. Leow, C. S. Tam, J. A. Woyach, T. A. Eyre

Get full text

S208: EFFICACY AND SAFETY OF ZANDELISIB ADMINISTERED BY INTERMITTENT DOSING (ID) IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF THE GLOBAL P... by A. Zelenetz, W. Jurczak, V. Ribrag, K. Linton, G. Collins, J. Lopéz-Jiménez, N. Reddy, A. Mengarelli, T. Phillips, G. Musuraca, O. Sheehy, J. Li, W. Xu, M. Azoulay, R. Ghalie, P. L. Zinzani

Get full text

P1087: FAVEZELIMAB (ANTI–LAG-3) AND PEMBROLIZUMAB CO-BLOCKADE IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA WHO PROGRESSED AFTER ANTI–PD-1 THERAPY: AN OPEN-LAB... by A. F. Herrera, D. Lavie, N. A. Johnson, A. Avigdor, P. Borchmann, C. Andreadis, A. Bazargan, G. Gregory, C. Keane, T. Inna, V. Vucinic, P. L. Zinzani, H. Zhang, P. Pillai, P. Marinello, J. Timmerman

Get full text

P1198: ASSOCIATION OF PRETREATMENT TUMOR CHARACTERISTICS AND CLINICAL OUTCOMES FOLLOWING SECOND-LINE AXICABTAGENE CILOLEUCEL VS STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTOR... by F. L. Locke, J. Chou, S. Vardhanabhuti, R. Perbost, P. Dreger, B. T. Hill, C. Lee, P. L. Zinzani, N. Kröger, A. López-Guillermo, H. Greinix, W. Zhang, G. Tiwari, C. To, P. Cheng, A. Bot, R. Shen, S. Filosto, J. Galon

Get full text

P1115: A MULTICENTER PHASE 1/2 TRIAL OF EO2463, A MICROBIAL-DERIVED PEPTIDE THERAPEUTIC VACCINE, AS MONOTHERAPY AND IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB, FOR TREATMENT OF... by P. L. Zinzani, S. M. Ansell, F. Bosch, J. W. Friedberg, J. P. Marolleau, L. Arcaini, R. Garcia-Sanz, A. K. Gopal, C. Grande, R. Merryman, A. Pinto, S. D. Smith, J. C. Villasboas, D. Wallace, J. Fagerberg, J. G. Magalhaes, P. Armand

Get full text

S217: PRELIMINARY ANALYSIS OF THE PHASE II STUDY USING TOLINAPANT (ASTX660) MONOTHERAPY IN 98 PERIPHERAL T-CELL LYMPHOMA AND 51 CUTANEOUS T-CELL LYMPHOMA SUBJECTS WITH RELAPSED REF... by J.-M. Michot, A. Mehta, F. Samaniego, E. Bachy, P. L. Zinzani, A. Prica, G. P. Colins, V Ribrag, N. Wagner-Johnston, D. El-Sharkawi, O. A. O’Connor, R. Wilcox, L. Wang, L. Wilson, M. Sims, J. A. Taylor, H. N. Keer, F. Foss

Get full text

P1138: COPANLISIB + RITUXIMAB VS RITUXIMAB + PLACEBO IN PATIENTS WITH RELAPSED INDOLENT NON-HODGKIN LYMPHOMA (NHL): UPDATED SAFETY AND EFFICACY FROM THE PHASE III CHRONOS-3 TRIAL by P. L. Zinzani, M. Özcan, K. Sapunarova, W. Jurczak, A. Hamed, K. Bouabdallah, G. Saydam, K. Geissler, Á. Szomor, M. Lazaroiu, A. Salar, A. Tempescul, M. Nalcaci, L. Gercheva, M. Egyed, P. Panayiotidis, L. Mongay Soler, A. Cao, C. Phelps, B. H Childs, M. J Matasar

Get full text

P1172: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA FROM THE PHASE 2 PRIMO TRIAL: UPDATED EXPANSION PHASE ANALYSIS by P. L. Zinzani, MD, PhD, J. Zain, MD, M. Mead, BS, MD, C. Casulo, MD, E. D. Jacobsen, MD, G. Gritti, MD, PhD, L. Pinter-Brown, MD, K. Isutzu, MD, D. Cohan, MD, M. Daugherty, PharmD, J. E. Brammer, MD, N. Mehta-Shah, MD, B. Pro, MD, S. M. Horwitz, MD

Get full text

S205: ZANUBRUTINIB + OBINUTUZUMAB (ZO) VS OBINUTUZUMAB (O) MONOTHERAPY IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PRIMARY ANALYSIS OF THE PHASE 2... by P. L. Zinzani, J. Mayer, R. Auer, F. Bijou, A. C. de Oliveira, C. R. Flowers, M. Merli, K. Bouabdallah, P. S. Ganly, Y. Song, H. Zhang, R. Johnson, A. M García-Sancho, M. Provencio, M. Trněný, S. Yuen, H. Tilly, E. Kingsley, G. Tuyman, S. E. Assouline, E. Ivanova, P. Kim, J. Huang, R. Delarue, J. Trotman

Get full text

S201: CAMIDANLUMAB TESIRINE: UPDATED EFFICACY AND SAFETY IN AN OPEN-LABEL, MULTICENTER, PHASE 2 STUDY OF PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL) by C. Carlo-Stella, S. Ansell, P. L Zinzani, J. Radford, K. Maddocks, A. Pinto, G. P. Collins, V. Bachanova, N. Bartlett, I. Bence-Bruckler, M. Hamadani, J. Kline, J. Mayer, K. J. Savage, R. Advani, P. Caimi, R.-O. Casasnovas, T. Feldman, B. Hess, M. Bastos-Oreiro, S. Iyengar, S. Eisen, Y. Negievich, L. Wang, J. Wuerthner, A. F. Herrera

Get full text

P1162: ZANUBRUTINIB IN OLDER PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): SUBGROUP ANALYSIS OF THE MAGNOLIA STUDY by S. Opat, B. Hu, A. Tedeschi, K. M. Linton, P. McKay, H. Chan, J. Jin, M. Sun, M. Sobieraj-Teague, P. L. Zinzani, M. Coleman, P. Browett, X. Ke, C. A. Portell, C. Thieblemont, K. Ardeshna, F. Bijou, P. Walker, E. A. Hawkes, S.-J. Ho, K.-S. Zhou, M. Co, J. Xu, Z. Liang, J. Anderson, C. Tankersley, J. Huang, J. Trotman

Get full text

P1239: TISLELIZUMAB, A PD-1 INHIBITOR FOR RELAPSED/REFRACTORY MATURE T- AND NK-CELL NEOPLASMS: RESULTS FROM A PHASE 2 STUDY by E. Bachy, K. J. Savage, H. Huang, Y. L. Kwong, G. Gritti, Q. Zhang, A. M. Liberati, J. Cao, H. Yang, S. Hao, J. Hu, K. Zhou, F. Russo, H. Zhang, W. Sang, J. Ji, A. J. M. Ferreri, G. L. Damaj, H. Liu, W. Zhang, X. Ke, C. Ghiggi, S. Huang, X. Li, H. Yao, J. Paik, W. Novotny, W. Zhou, H. Zhu, J. Huang, P. L. Zinzani

Get full text

S101: GENETIC AND EPIGENETIC FACTORS DRIVING PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATHOGENESIS AND OUTCOME by D. Noerenberg, F. Briest, C. Hennch, K. Yoshida, J. Nimo, R. Hablesreiter, Y. Takeuchi, D. Sasca, H. Ueno, L. Mansouri, Y. Inoue, L. Wiegand, A. M. Staiger, B. Casadei, M. Ziepert, F. Asmar, P. Korkolopoulou, M. Kirchner, P. Mertins, J. Weiner, E. Toth, T. Weber, A. Warth, T. Schneider, R.-M. Amini, W. Klapper, M. Hummel, V. Poeschel, G. Kanellis, A. Rosenwald, G. Held, E. Campo, K. Stamatopoulos, I. Anagnostopoulos, L. Bullinger, N. Goldschmidt, P. L. Zinzani, C. Bödor, R. Rosenquist, T. P. Vassilakopoulos, G. Ott, S. Ogawa, F. Damm

Get full text